Navigation Links
Nuvilex Introduces Last Shot Hangover Remedy(TM) Video
Date:8/27/2009

e Company.

Safe Harbor Statement

Statements contained in this presentation that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Forward-looking statements are sometimes identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and involve a number of risks and uncertainties that could cause the Company's actual results to differ materially from projected results. All parties are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, the planned share exchange with Freedom2 Holdings, Inc., our ability to secure additional financing, and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

    Company Contact:

    Blair Barnes
    Senior Vice President and Chief Financial Officer
    Nuvilex, Inc.
    Ph: 856-433-6088
    Email: bbarnes@nuvilex.com

    Press Contact:

    Pat Arcand
    Arcand & Madison
    Ph: 617-576-7777
    Email: pat@am-pr.com


'/>"/>
SOURCE Nuvilex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Nuvilex Launches Last Shot Hangover Remedy(TM) Web Site
2. Nuvilex to Issue Positive Shareholder Newsletter
3. Nuvilex Completes First Sale of Last Shot Hangover Remedy(TM)
4. Nuvilex, Inc. Announces Business Update Conference Call
5. Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health
6. Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream
7. Nuvilex Featured in Wall Street Reporter Interview
8. Nuvilex Offers Free Cinnergen Samples in Response to Spike in Consumer Interest
9. Nuvilex Launches Video Marketing Campaign
10. Nuvilex Gets Update from CK41 on purEffect(TM) Launch Plan
11. Nuvilex Signs Agreement with Jayhur Enterprises to Distribute Infinitink - the Worlds First Permanent, But Easier to Remove Tattoo Ink - in Australia and New Zealand

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...RNewswire/--Whiletheholidayseasonoftenbringsfamili...anbedifficultforthosegrievingthedeathofalovedone.F...milies.Theholidayseasoncanbringadditionalchallenge...ce,ACenterforGrievingChildren,AdolescentsandTheirF...ontohavingavarietyofprintandonlineresourcesavailab...
(Date:11/24/2009)...Nov.24/PRNewswire/--Bionorica,aninternationalcompa...uncedtodaytheavailabilityofneweducationalresources...th.Atipsheeton"StayingNaturallyHealthyduringtheHol...wavailableonthecompany,swebsiteat www.bionoricausa...ubscriptiontotheNaturalMomstipsheets,withcontentco...
(Date:11/24/2009)...ewswire-FirstCall/--CenteneCorporation(NYSE: CNC )...hasselectedCenteneasoneoftwoCoordinatedCareOrganiz...ssNetwork(MississippiCAN),acoordinatedcareprogramf...gwiththeDivisiontoexecuteacontractinwhichthecompan...oliaHealthPlan(Magnolia). ,, BasedinJackson,Mis...
(Date:11/24/2009)...mproves heart prospects, but cancer risk remains ,...A new study offers yet more proof that smoking is ...nd cancer. , Researchers followed 12,152 Americ...mokers and nonsmokers for three years. During that... to die of cancer, 2.26 times more likely to die o...
(Date:11/24/2009)... have found that hormones produced during pregnanc...th of breast cancer. This protein, alpha-fetoprote...ent for the treatment and prevention of breast can...evention Research , a journal of the American Asso...gnancy, such as estrogen, all induce AFP, which di...
Breaking Medicine News(10 mins):Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Bionorica Offers Expert Resources, Health Tips for 'Natural Moms' 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Smokers Double Their Risk for Heart Disease 2Health News:Protein from pregnancy hormone may prevent breast cancer 2
... N.J., April 15 MedQuist Inc. (Nasdaq: MEDQ ) t...ts new Chief Financial Officer. He joined MedQuis...t,s new CFO, Golio is responsible for directing al.... "Dominick,s broad experience as a Chief Financi...
...uck an industry trend and boost enrollments , , D...omy struggles, many health and fitness clubs conti...nchisees of Planet Fitness, however, the fastest g...ps totaling in the six figures. , , The campaign,...
...ons Give Employees More Flexibility and Ease Admin...The Guardian Life Insurance Company of America (Gu...ary benefits for small and mid-sized companies, to...rization, providing faster, easier access to impor...
...ological differences in toddlers born to drug abus...s) -- In what researchers are calling the first st...t women has been found to prompt abnormal brain de...pert said. , "If we accept the conclusion here tha...
...N.C., April 15 TSI Healthcare, a national leader ...election and implementation, and The SURVE Consult...resource firm, have announced a strategic alliance..., TSI (and its subsidiaries) currently has approxi...
...rdt and the Council for American Medical Innovatio...tion" in Chicago, featuring David Brennan, CEO of ...IO, academics and patient advocates , , CHICAGO,...atient advocacy to address the importance of medic...
Other Medicine News:Health News:MedQuist Names Dominick J. Golio as Chief Financial Officer 2Health News:Despite Ailing Economy, Planet Fitness Thrives 2Health News:New Program Gives Guardian Dental Pre-Paid/DHMO Members Greater Access to Specialty Care 2Health News:Fetal Exposure to Methamphetamine May Harm Child's Brain 2Health News:TSI Healthcare and SURVE Consulting Announce a Strategic Alliance for Leadership and Business Development 2Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 2Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 3Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 4
(Date:11/24/2009)...ciencesCorporationannouncedtodaythattherewillbemul...rationFLT3inhibitor,inAMLatthe51stAmericanSocietyo...LA,December5-8,2009.Anoralpresentationwillhighligh...tystudyinadultswithacutemyeloidleukemia(AML).Addit...heeffectofAC220monotherapyandincombinationwithchem...
(Date:11/24/2009)...FirstCall/--CardioGenicsHoldingsInc.(OTCBulletinBo...ngtheimmunoassaysegmentoftheIVDtestingmarket,repor...gtothenextphaseofthecommercializationofCardioGenic...). ,, PertheagreementwithMerckChimiethatwasexec...ewithitsproprietarysilvercoatedparamagneticbeadsfo...
(Date:11/24/2009)...Call/--EchoTherapeutics,Inc.(OTCBulletinBoard:ECTE...Systemasanon-invasive,wireless,transdermalcontinuo...inPrepSystemfortransdermaldrugdelivery,announcedto...iveOfficer,willpresentatthe13thAnnualBiotechandSpe...orkSocietyofSecuritiesAnalysts,at2:05onDecember1,2...
Breaking Medicine Technology:Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Patch Shots May Someday Replace Injections 54893 1Patch Shots May Someday Replace Injections 54893 2Vanderbilt joins national consortium to develop new cancer therapies 54888 1Vanderbilt joins national consortium to develop new cancer therapies 54888 2Vanderbilt joins national consortium to develop new cancer therapies 54888 3American Society for Microbiology honors Anton Y Peleg 9618 1American Society for Microbiology honors Anton Y Peleg 9618 2American Society for Microbiology honors Anton Y Peleg 9618 3American Society for Microbiology honors Anton Y Peleg 9618 4
...re than 10 years, Mark Wentland, professor of chem...nic Institute , led a Rensselaer team in the disco...s with the potential to treat nervous system disor...censed to Alkermes Inc., and the company identifie...cal trials with the candidate, known as ALKS 33, b...
...en(TM), Inc. (NYSE Amex: ILE ) today announced t... ("FDA") has completed its initial review of the C...ated to its Nasolabial Fold/Wrinkles product candi...BLA for full review. , , In a communication recei...t it had completed its initial review of the Compa...
Other Medicine Technology:One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 2One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 3One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 4One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 5One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 6Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 2Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 3
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: